Search
Displaying 881–890 of 1059 results for “fc 26 ps4 coins Visit Buyfc26coins.com for latest FC 26 coins news..NH7v”
-
Most people are able to make a far more significant gift by including the Foundation in their will or trust or making a gift by beneficiary designation. Often called “legacy gifts”, these types of deferred gifts allow you to continue to be part of ending blindness for many decades to come.
-
Foundation News
My Retina Tracker Program is the highest volume IRD genetic testing program in the U.S.
-
At the Foundation Fighting Blindness, our employees are true beacons of hope as they are committed to our urgent mission to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases.
-
Coping with a Vision Loss Diagnosis
Being diagnosed with an eye condition that causes partial or complete vision loss is a highly emotional experience. Vision loss may come unexpectedly and be frightening. Newly-diagnosed patients frequently struggle with grief and depression, similar to losing a loved one. When managed using healthy coping methods and strategies, this is a natural and normal response to vision loss.
-
Jack Sees a Different Life after LUXTURNA
Beacon StoriesJack Hogan was diagnosed with retinitis pigmentosa at only two-and-a-half years old. But with the help of connections made with the Foundation, Jack became the first-ever recipient of the FDA-approved gene therapy known as LUXTURNA.
-
ARVO 2019: Emerging Eloxx Molecules Show Promising Results in Usher Models
Research NewsEloxx Pharmaceuticals is developing small molecules that permit read-through of point mutations that cause Usher syndrome 1F and 2A.
-
About Page
Roster of the Foundation Fighting Blindness Scientific Advisory Board
-
Clinical Trials that are open now
-
ARVO 2018: Dr. Henry Klassen Provides Update on jCyte Stem Cell Trials
Research NewsDr. Henry Klassen, jCyte co-founder and investigator at UC Irvine, provides an update on the clinical trials for an RP therapy derived from stem cells.
